Skip to main content

Genital Human Papilloma Virus Infection

0
Pipeline Programs
3
Companies
21
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

MSD
MSDIreland - Ballydine
1 program
GardasilN/A
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
GardasilN/A
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
GardasilN/A5 trials
Active Trials
NCT07224477Not Yet Recruiting525Est. Apr 2028
NCT06688058Active Not Recruiting72Est. Nov 2026
NCT06623409Active Not Recruiting72Est. Nov 2026
+2 more trials

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil
Merck & Co.Gardasil

Showing 15 of 21 trials with date data

Clinical Trials (21)

Total enrollment: 604,610 patients across 21 trials

Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwanda

Start: Sep 2024Est. completion: Mar 2026100,000 patients
Phase 4Not Yet Recruiting

HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in Eswatini

Start: Apr 2022Est. completion: Dec 20241,403 patients
Phase 4Completed

An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen

Start: Dec 2020Est. completion: Oct 2026352 patients
Phase 4Active Not Recruiting

HPV Vaccination Study in Postpartum Women

Start: Aug 2020Est. completion: Feb 2023225 patients
Phase 4Completed

Postpartum HPV Vaccination

Start: Apr 2019Est. completion: Dec 2020195 patients
Phase 4Completed

Acceptability of Human Papillomavirus (HPV) Vaccine in Female Sex Workers

Start: Oct 2009Est. completion: Aug 2011200 patients
Phase 4Completed

A Clinical Study of V540A in Healthy Female Participants (V540A-005)

Start: Jul 2026Est. completion: Apr 2028525 patients
Phase 2Not Yet Recruiting

Study of Gardasil in Mid-Adult Males (MAM)

Start: Feb 2013Est. completion: Nov 2020150 patients
Phase 2Completed

A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004)

Start: Dec 2024Est. completion: Nov 202672 patients
Phase 1Active Not Recruiting

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Start: Nov 2024Est. completion: Nov 202672 patients
Phase 1Active Not Recruiting

Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old

Start: Sep 2022Est. completion: Dec 2028155 patients
Phase 1Active Not Recruiting

The Development of a "Mother/Child, Screen, Treat and Vaccinate Program" in Manchay and Iquitos, Peru

Start: May 2011Est. completion: Apr 2012642 patients
Phase 1Completed

Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

Start: Aug 2024Est. completion: Jul 202534 patients
N/ATerminated

Gardasil Immunogenicity With Needle-Free Injection

Start: Jan 2014Est. completion: May 2016150 patients
N/ACompleted

Effectiveness of SMS (Short Message Service) Text Messaging in Increasing Adherence to Gardasil

Start: Jan 2011Est. completion: Jun 201622 patients
N/ATerminated

A Model for Implementation of Cervical Cancer Screening and HPV Vaccination the Emergency Department: a Pilot Study

Start: Sep 2009Est. completion: Oct 2012100 patients
N/AUnknown

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Start: Dec 2008Est. completion: Aug 201567 patients
N/ACompleted

Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

Start: Jul 2008Est. completion: Apr 201153 patients
N/ACompleted

Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men

Start: Jun 2008Est. completion: Jun 2012150 patients
N/AUnknown

Safety and Efficacy of Gardasil in Females With Juvenile Idiopathic Arthritis (JIA)/Seronegative Arthritis

Start: Nov 2007Est. completion: Oct 201443 patients
N/ACompleted

Effectiveness Study of Gardasil on Condyloma

Start: Jun 2006Est. completion: Dec 2010500,000 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.